EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The newly identified grdA gene confers high-level plazomicin resistance in Salmonella enterica serovars

Ahmed F Hikal iD, Shaohua Zhao, Steven Foley iD, Ashraf A Khan iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.01606-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Ahmed F Hikal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Salmonella enterica, Sisomicin, Bacterial Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Food and Drug Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plazomicin, a next-generation aminoglycoside, was recently approved by the U.S. Food and Drug Administration for the treatment of multidrug-resistant complicated urinary tract infections. It is highly effective against most aminoglycoside-modifying enzymes (AMEs). Here, we report that Salmonella enterica strains containing the newly identified gentamicin resistance gene ( grdA ) are highly resistant to plazomicin. Heterologous expression of grdA in Escherichia coli Δ tolC resulted in plazomicin resistance with minimum inhibitory concentration (MIC) > 256 µg/mL. These findings reveal that GrdA confers significantly higher resistance to plazomicin than the previously known plazomicin-resistant AMEs AA (2)-Ia and APH (2″)-Iva.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsSalmonella entericaSisomicinBacterial ProteinsMicrobial Sensitivity TestsEscherichia coliGentamicinsDrug Resistance, Multiple, BacterialDrug Resistance, Bacterial

Stichwörter der Autor:innen

Salmonella entericagrdAplazomicin resistance

Substanzen

Anti-Bacterial AgentsSisomicinplazomicinGentamicinsBacterial Proteins

Autor:innen und Institutionen

  • Division of Microbiology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas, USA.
  • Office of Applied Science, Center for Veterinary Medicine, U.S. Food and Drug Administration, Laurel, Maryland, USA.

ORCID-Profile: Ahmed F Hikal, Steven Foley, Ashraf A Khan

Förderung

  • U.S. Food and Drug Administration

Zitieren

APA

Hikal, A. F., Zhao, S., Foley, S., & Khan, A. A. (2025). The newly identified grdA gene confers high-level plazomicin resistance in Salmonella enterica serovars. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01606-24

Vancouver

Hikal AF, Zhao S, Foley S, Khan AA. The newly identified grdA gene confers high-level plazomicin resistance in Salmonella enterica serovars. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01606-24

BibTeX
@article{Hikal2025,
  author = {Hikal, Ahmed F and Zhao, Shaohua and Foley, Steven and Khan, Ashraf A},
  title = {The newly identified grdA gene confers high-level plazomicin resistance in Salmonella enterica serovars},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.01606-24}
}
Kostenlos starten →